Tranexamic Acid in Surgery of Advanced Ovarian Cancer - a Prospective Randomized Double Blind Placebo Controlled Study
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Perioperative bleeding volume
From start of operation to discharge from hospital
No
Ulf Leandersson, MD
Principal Investigator
Dept. of Obstetrics and Gynecology, Kalmar Central Hospital, 391 85 Kalmar
Sweden: Medical Products Agency
EudraCT nr 2006-006714-14
NCT00740116
March 2008
June 2012
Name | Location |
---|